申请人:O'Connor Stephen J.
公开号:US06919371B2
公开(公告)日:2005-07-19
This invention relates to novel 2,6-substituted chroman derivatives which are useful in the treatment of beta-3 adrenoreceptor-mediated conditions.
本发明涉及一种新型的2,6-取代的色甘醇衍生物,可用于治疗β-3肾上腺素能受体介导的疾病。